Amgen is lagging behind rivals like Novo Nordisk and Eli Lilly with its new-generation therapy for obesity, but is sufficiently encouraged by early-stage clinical data to kick off a phase 2 programme ...

Every time James publishes a story, you’ll get an alert straight to your inbox! Enter your email By clicking “Sign up”, you agree to receive emails from ...

As frustrating as it is that governments and businesses are running roughshod over our online freedoms, at least we have plenty of good VPNs to choose from to keep us protected online. There are so ...